Biotech Updates

Scientists Develop New CRISPR Platform for DNA Targeting

January 23, 2019

Expert from Broad Institute of MIT and Harvard and partners reported another CRISPR system called Cas12b. This new system has improved capabilities and potential applications compared to CRISPR-Cas9 systems. The study is published in Nature Communications.

According to the researchers, the new enzyme can be designed to target and precisely nick or edit the genomes of human cells. The small size and high target specificity of Cas12b from Bacillus hisashii (BhCas12b) as compared to Cas9 (SpCas9) makes it optimal for in vivo applications. The research team is currently developing CRISPR-Cas12b widely available for research.

Read more from MIT News.